Human Placental Lactogen (hPL) Rabbit Polyclonal Antibody
Specialties: Genitourinary (GU) Pathology
Human placental lactogen (hPL), also previously known as ‘human chorionic somatomammotropin’, is a 22-kD protein with partial homology to growth hormone. hPL is first detectable in the maternal serum in the fifth week of gestation and is involved in maintaining nutritient supply to the fetus. Anti-hPL reactivity is seen in syncytiotrophoblastic cells of placenta and choriocarcinoma.1-2
- Shih IM, et al. p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol. 2004; 28:1177-83.
- Ulbright TM, et al. Trophoblastic tumors of the testis other than classic choriocarcinoma: monophasic choriocarcinoma and placental site trophoblastic tumor: a report of two cases. Am J Surg Pathol. 1997; 21:282-8.
Specifications
- Reactivity: paraffin
- Visualization: cytoplasmic
- Control: placenta
- Dilution Range: 1:50-1:200*
Package Inserts
IFU
- IVD Rev. 4.0 (CMC26611040)
Have a different keycode?
Click Here
Learn how to obtain your SDS
Ordering Information
For in vitro diagnostic (IVD) use in USA
0.1 mL concentrate | 266A-14 |
0.5 mL concentrate | 266A-15 |
1 mL concentrate | 266A-16 |
1 mL predilute | 266A-17 |
7 mL predilute | 266A-18 |
For in vitro diagnostic (IVD) use in Canada
0.1 mL concentrate | 266A-14 |
0.5 mL concentrate | 266A-15 |
1 mL concentrate | 266A-16 |
1 mL predilute | 266A-17 |
7 mL predilute | 266A-18 |
For in vitro diagnostic (IVD) use in Europe
0.1 mL concentrate | 266A-14 |
0.5 mL concentrate | 266A-15 |
1 mL concentrate | 266A-16 |
1 mL predilute | 266A-17 |
7 mL predilute | 266A-18 |
For research use only (RUO) in Japan
0.1 mL concentrate | 266A-14-RUO |
0.5 mL concentrate | 266A-15-RUO |
1 mL concentrate | 266A-16-RUO |
1 mL predilute | 266A-17-RUO |
7 mL predilute | 266A-18-RUO |
To request information on this product in additional countries, please click the button below.